Tag: Alzheimer’s
U.S. Sets Up $300 Million Database for Alzheimer Disease Research
In creating the database, the goal is to provide something that can 'improve applicability and generalizability of findings'
Readmission Rates, Episode Costs Increased for Patients With Dementia
Cost of 30-day readmission and total 30-day episode costs higher for patients with Alzheimer disease and related dementias
Risk for Neurodegenerative Disease Increased for Soccer Players
Increased risk seen for Alzheimer disease and other dementias, but no increase seen for motor neuron disease or Parkinson disease
Less Postmortem Alzheimer Disease Pathology Seen With MIND, Mediterranean Diets
Global Alzheimer disease pathology lower in patients following these dietary patterns, specifically less beta-amyloid load
Certain Genetic Variant in Alzheimer Disease Linked to African Ancestry
Increased risk for Alzheimer disease and younger age of onset seen with APOE ε3 R145C missense variation
Social Isolation Tied to Wide Variety of Dementia Risk Factors
Social isolation may be a modifiable risk factor for preventing Alzheimer disease-related dementias, authors say
Plasma Biomarkers Identified for Detecting Presymptomatic Alzheimer Disease
Plasma P-tau181, NfL, GFAP concentrations higher in mutation carriers versus noncarriers of autosomal dominant Alzheimer disease
Vascular Risk Factors Only Explain Part of Alzheimer Disease Risk for Blacks, Hispanics
Barriers to health care access and other socioeconomic factors may increase vulnerability in racial/ethnic minorities
PTSD, TBI Interact With APOE ε4 to Raise Alzheimer, Dementia Risk
Significant additive APOE ε4 interactions seen with PTSD and TBI in veterans of European ancestry
FDA Approves Second Drug for Alzheimer Disease, Despite Safety Concerns
Approval of Leqembi comes after controversial approval in 2021 of Aduhelm, which met with criticism over concerns about that drug's effectiveness, safety, pricing
